Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Is she saying that TLT can get fund rather than PP in 2024?

<< Previous

Bullboard Posts

Next >>

Comment by Donein25on Mar 28, 2024 7:46pm

264 Views

Post# 35959417

RE:RE:RE:RE:RE:RE:Is she saying that TLT can get fund rather than PP in 2024?

I would expect a PR at 7am Wednesday. We have never had a conference call/ Zoom meeting announced after a financial release, until now. Heck we don't even get Zoom calls for AGMs (despite my pleas in the past). Something must be coming.... my guess is a debt offering,or maybe less likely another shot at a public offering.

<< Previous

Bullboard Posts

Next >>

Investors eye Australian gold mining projects amid promising developments